Literature DB >> 23427282

High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway.

Bin Dong1, Chin Fung Kelvin Kan, Amar B Singh, Jingwen Liu.   

Abstract

Long-chain acyl-CoA synthetases (ACSL) play key roles in fatty acid metabolism in liver and other metabolic tissues in an isozyme-specific manner. In this study, we examined the effects of a fructose-enriched diet on expressions of ACSL isoforms in the liver of hamsters. We showed that the fructose diet markedly reduced the mRNA and protein expressions of ACSL3 in hamster liver without significant effects on other ACSLs. The decrease in ACSL3 abundance was accompanied by a reduction in ACSL-catalyzed synthesis of arachidonyl-CoA and oleoyl-CoA in liver homogenates of hamsters fed the fructose diet as opposed to normal diet. We further showed that fructose diet specifically reduced expressions of three key components of the LXR signaling pathway, namely, liver X receptor (LXR)α, LXRβ, and retinoid X receptor (RXR)β. Exogenous expression and activation of LXRα/β increased hamster ACSL3 promoter activities in a LXR-responsive element (LXRE)-dependent fashion. Finally, we showed that treating hamsters with LXR agonist GW3965 increased hepatic ACSL3 expression without affecting other ACSL isoforms. Furthermore, the ligand-induced increases of ACSL3 expression were accompanied with the reduction of hepatic triglyceride levels in GW3965-treated hamster liver. Altogether, our studies demonstrate that fructose diet has a negative impact on LXR signaling pathway in liver tissue and reduction of ACSL3 expression/activity could be a causal factor for fructose-induced hepatic steatosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23427282      PMCID: PMC3622321          DOI: 10.1194/jlr.M032599

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  47 in total

1.  Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.

Authors:  François Briand; Morgan Tréguier; Agnès André; Didier Grillot; Marc Issandou; Khadija Ouguerram; Thierry Sulpice
Journal:  J Lipid Res       Date:  2009-10-27       Impact factor: 5.922

2.  Activation of LXR increases acyl-CoA synthetase activity through direct regulation of ACSL3 in human placental trophoblast cells.

Authors:  M Susanne Weedon-Fekjaer; Knut Tomas Dalen; Karianne Solaas; Anne Cathrine Staff; Asim K Duttaroy; Hilde Irene Nebb
Journal:  J Lipid Res       Date:  2010-03-10       Impact factor: 5.922

3.  Adipose acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis.

Authors:  Jessica M Ellis; Lei O Li; Pei-Chi Wu; Timothy R Koves; Olga Ilkayeva; Robert D Stevens; Steven M Watkins; Deborah M Muoio; Rosalind A Coleman
Journal:  Cell Metab       Date:  2010-07-07       Impact factor: 27.287

4.  Long-chain acyl-CoA synthetases and fatty acid channeling.

Authors:  Douglas G Mashek; Lei O Li; Rosalind A Coleman
Journal:  Future Lipidol       Date:  2007-08

5.  Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes.

Authors:  Lei O Li; Douglas G Mashek; Jie An; Scott D Doughman; Christopher B Newgard; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2006-10-06       Impact factor: 5.157

6.  Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin.

Authors:  David J Durgan; Justin K Smith; Margaret A Hotze; Oluwaseun Egbejimi; Karalyn D Cuthbert; Vlad G Zaha; Jason R B Dyck; E Dale Abel; Martin E Young
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-01-20       Impact factor: 4.733

7.  Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.

Authors:  Jessica M Ellis; Shannon M Mentock; Michael A Depetrillo; Timothy R Koves; Shiraj Sen; Steven M Watkins; Deborah M Muoio; Gary W Cline; Heinrich Taegtmeyer; Gerald I Shulman; Monte S Willis; Rosalind A Coleman
Journal:  Mol Cell Biol       Date:  2011-01-18       Impact factor: 4.272

Review 8.  Metabolic effects of fructose and the worldwide increase in obesity.

Authors:  Luc Tappy; Kim-Anne Lê
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice.

Authors:  Kara N Maxwell; Raymond E Soccio; Elizabeth M Duncan; Ephraim Sehayek; Jan L Breslow
Journal:  J Lipid Res       Date:  2003-08-01       Impact factor: 5.922

10.  LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.

Authors:  Elaine M Quinet; Michael D Basso; Anita R Halpern; David W Yates; Robert J Steffan; Valerie Clerin; Christine Resmini; James C Keith; Thomas J Berrodin; Irene Feingold; Wenyan Zhong; Helen B Hartman; Mark J Evans; Stephen J Gardell; Elizabeth DiBlasio-Smith; William M Mounts; Edward R LaVallie; Jay Wrobel; Ponnal Nambi; George P Vlasuk
Journal:  J Lipid Res       Date:  2009-03-24       Impact factor: 5.922

View more
  20 in total

Review 1.  Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update.

Authors:  Sheng Yan; Xue-Feng Yang; Hao-Lei Liu; Nian Fu; Yan Ouyang; Kai Qing
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.

Authors:  Chin Fung Kelvin Kan; Amar Bahadur Singh; Bin Dong; Vikram Ravindra Shende; Jingwen Liu
Journal:  Biochim Biophys Acta       Date:  2015-01-31

Review 3.  Acyl-CoA metabolism and partitioning.

Authors:  Trisha J Grevengoed; Eric L Klett; Rosalind A Coleman
Journal:  Annu Rev Nutr       Date:  2014-04-10       Impact factor: 11.848

4.  Slc43a3 is a regulator of free fatty acid flux.

Authors:  Kathrin B Hasbargen; Wen-Jun Shen; Yiqiang Zhang; Xiaoming Hou; Wei Wang; Qui Shuo; David A Bernlohr; Salman Azhar; Fredric B Kraemer
Journal:  J Lipid Res       Date:  2020-03-26       Impact factor: 5.922

5.  High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice.

Authors:  Joshua S Wooten; Tayler N Nick; Andrew Seija; Kaylee E Poole; Kelsey B Stout
Journal:  J Clin Exp Hepatol       Date:  2016-09-08

6.  SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter.

Authors:  Amar Bahadur Singh; Chin Fung Kelvin Kan; Bin Dong; Jingwen Liu
Journal:  J Biol Chem       Date:  2016-01-04       Impact factor: 5.157

7.  A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression.

Authors:  Amar Bahadur Singh; Chin Fung Kelvin Kan; Vikram Shende; Bin Dong; Jingwen Liu
Journal:  J Lipid Res       Date:  2014-05-02       Impact factor: 5.922

8.  Regulation of lipid metabolism by obeticholic acid in hyperlipidemic hamsters.

Authors:  Bin Dong; Mark Young; Xueqing Liu; Amar Bahadur Singh; Jingwen Liu
Journal:  J Lipid Res       Date:  2016-12-09       Impact factor: 5.922

9.  Lxr-driven enterocyte lipid droplet formation delays transport of ingested lipids.

Authors:  Lourdes Cruz-Garcia; Amnon Schlegel
Journal:  J Lipid Res       Date:  2014-07-16       Impact factor: 5.922

10.  CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism.

Authors:  Bin Dong; Amar Bahadur Singh; Chin Fung; Kelvin Kan; Jingwen Liu
Journal:  Atherosclerosis       Date:  2014-06-04       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.